Choline and its metabolites are differently associated with cardiometabolic risk factors, history of cardiovascular disease, and MRI-documented cerebrovascular disease in older adults

• Published in: The American journal of clinical nutrition 2017-06, Vol.105 (6), p.1283-1290
• Main Authors: Roe, Annie J, Zhang, Shucha, Bhadelia, Rafeeque A, Johnson, Elizabeth J, Lichtenstein, Alice H, Rogers, Gail T, Rosenberg, Irwin H, Smith, Caren E, Zeisel, Steven H, Scott, Tammy M
• Format: Article
• Language: English
• Subjects: Adults; Aged; Aged, 80 and over; Aging; Betaine; Betaine - blood; Body mass; Body Mass Index; Body size; Brain; C-reactive protein; C-Reactive Protein - metabolism; Cardiovascular disease; Cardiovascular diseases; Cardiovascular Diseases - blood; Cerebrovascular Disorders - blood; Cerebrovascular Disorders - pathology; Cholesterol; Cholesterol - blood; Choline; Choline - blood; Cross-Sectional Studies; Diabetes mellitus; Diabetes Mellitus - blood; Dilution; Female; Health risks; High density lipoprotein; Homocysteine; Homocysteine - blood; Humans; Hypertension; Hypertension - blood; Lecithin; Lipid metabolism; Low density lipoprotein; Magnetic resonance imaging; Magnetic Resonance Spectroscopy; Male; Mass spectrometry; Mass spectroscopy; Metabolism; Metabolites; Middle Aged; NMR; Nuclear magnetic resonance; Nutrition; Older people; Pathogenesis; Pathology; Phosphatidylcholine; Phosphatidylcholines - blood; Regression analysis; Regression models; Risk analysis; Risk Factors; Substantia alba; Triglycerides; Triglycerides - blood; Vascular diseases; Volumetric analysis; Waist Circumference
• ISSN: 0002-9165; 1938-3207
• DOI: 10.3945/ajcn.116.137158

There is a potential role of choline in cardiovascular and cerebrovascular disease through its involvement in lipid and one-carbon metabolism. We evaluated the associations of plasma choline and choline-related compounds with cardiometabolic risk factors, history of cardiovascular disease, and cerebrovascular pathology. A cross-sectional subset of the Nutrition, Aging, and Memory in Elders cohort who had undergone MRI of the brain ( = 296; mean ± SD age: 73 ± 8.1 y) was assessed. Plasma concentrations of free choline, betaine, and phosphatidylcholine were measured with the use of liquid-chromatography-stable-isotope dilution-multiple-reaction monitoring-mass spectrometry. A volumetric analysis of MRI was used to determine the cerebrovascular pathology (white-matter hyperintensities and small- and large-vessel infarcts). Multiple linear and logistic regression models were used to examine relations of plasma measures with cardiometabolic risk factors, history of cardiovascular disease, and radiologic evidence of cerebrovascular pathology. Higher concentrations of plasma choline were associated with an unfavorable cardiometabolic risk-factor profile [lower high-density lipoprotein (HDL) cholesterol, higher total homocysteine, and higher body mass index (BMI)] and greater odds of large-vessel cerebral vascular disease or history of cardiovascular disease but lower odds of small-vessel cerebral vascular disease. Conversely, higher concentrations of plasma betaine were associated with a favorable cardiometabolic risk-factor profile [lower low-density lipoprotein (LDL) cholesterol and triglycerides] and lower odds of diabetes. Higher concentrations of plasma phosphatidylcholine were associated with characteristics of both a favorable cardiometabolic risk-factor profile (higher HDL cholesterol, lower BMI, lower C-reactive protein, lower waist circumference, and lower odds of hypertension and diabetes) and an unfavorable profile (higher LDL cholesterol and triglycerides). Choline and its metabolites have differential associations with cardiometabolic risk factors and subtypes of vascular disease, thereby suggesting differing roles in the pathogenesis of cardiovascular and cerebral large-vessel disease compared with that of small-vessel disease.